Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Diabetes

Free Subscription 06.04.2026 2 Am J Clin Nutr 1 Am J Ophthalmol 1 Ann Intern Med 1 Biochem Biophys Res Commun 2 BMC Ophthalmol 1 BMC Pediatr 1 BMJ 2 Circulation 14 Diabet Med 3 Diabetes 9 Diabetes Care 11 Diabetes Obes Metab 2 Diabetologia 1 J Am Coll Cardiol 1 J Am Soc Nephrol 1 J Biol Chem 2 J Diabetes Complications 1 J Nutr 2 JAMA 1 Metabolism 1 N Engl J Med 1 Nutr Metab (Lond) 1 Pediatr Diabetes 1 PLoS Genet 11 PLoS One 1 Retina 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Nutr

1. YANG J, Mramba LK, Hard Af Segerstad EM, Kurppa K, et al
   Longitudinal Micronutrient Exposure Reveals Country-Specific Associations with Risk of Celiac Disease in Genetically Susceptible Children: The Prospective TEDDY Cohort: Nutrient Intake and Risk of Celiac Disease.
   Am J Clin Nutr. 2026 Mar 16:101276. doi: 10.1016/j.ajcnut.2026.101276.
   PubMed         Abstract available
   
   
2. MEER R, Xu JY, Newsom SP, Pasch A, et al
   Magnesium Supplementation did not Reduce Serum Calciprotein Crystallization and Arterial Stiffness in Individuals with Type 2 Diabetes: a Randomized, Double-blind, Placebo-controlled Trial.
   Am J Clin Nutr. 2026 Mar 26:101299. doi: 10.1016/j.ajcnut.2026.101299.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

3. KAKIHARA S, Busza AM, Duffy BV, Zhuang K, et al
   Macular OCTA Biomarkers Predict Regional Retinal Nonperfusion Patterns on Ultra-Widefield Angiography in Diabetes.
   Am J Ophthalmol. 2026 Mar 28:S0002-9394(26)00161.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

4. BOYE KS, Sharma P, Chivukula KK, Farrell EB, et al
   Patient-Reported Outcomes in People With Type 2 Diabetes Escalating Dulaglutide or Switching From Dulaglutide to Tirzepatide.
   Ann Intern Med. 2026 Mar 31. doi: 10.7326/ANNALS-25-03219.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

5. TAN H, Li Y, Li Y, Chen J, et al
   Glabridin attenuates diabetic cardiomyopathy by activating AMPK to suppress ferroptosis and TGF-beta-mediated myocardial fibrosis.
   Biochem Biophys Res Commun. 2026;815:153580.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

6. KROGH K, Agledahl KM, Bergmo TS, Erke MG, et al
   Diabetic retinopathy screening in a high-latitude rural population of Northern Norway.
   BMC Ophthalmol. 2026;26:160.
   PubMed         Abstract available
   
   
7. KIRCALI IK, Karti O, Ayhan Z, Utine CA, et al
   Safety profile of same-day bilateral intravitreal dexamethasone implantation for diabetic and uveitic macular edema: a single-center experience.
   BMC Ophthalmol. 2026 Mar 27. doi: 10.1186/s12886-026-04761.
   PubMed        
   
   

   
   BMC Pediatr

8. NYANFUL P, Korsah KA, Tornu E, Ameyaw E, et al
   Psychosocial challenges of adolescents living with type 1 diabetes mellitus: a qualitative study.
   BMC Pediatr. 2026 Mar 30. doi: 10.1186/s12887-026-06799.
   PubMed        
   
   

   
   BMJ

9. HAMMAD H
   The wellness inspired rise of continuous glucose monitors for people without diabetes, including those with metabolic disorders.
   BMJ. 2026;392:s441.
   PubMed        
   
   

   
   Circulation

10. GAO P, Li L, Zou Y
    Response by Gao et al to Letter Regarding Article, "G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice".
    Circulation. 2026;153:e1057.
    PubMed        
    
    
11. WU D, Zhang J, Yang J
    Letter by Wu et al Regarding Article, "G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice".
    Circulation. 2026;153:e1055-e1056.
    PubMed        
    
    

    
    Diabet Med

12. MITCHELL S, Patwardhan K, Lucocq J, Geropoulos G, et al
    Metabolic and bariatric surgery for patients with obesity type 1 diabetes mellitus: A comprehensive updated systematic review and meta-analysis.
    Diabet Med. 2026 Mar 28:e70305. doi: 10.1111/dme.70305.
    PubMed         Abstract available
    
    
13. DEV V, Consedine NS, Boggiss A, Serlachius A, et al
    A systematic review of the use of artificial intelligence in mental health-based diabetes care: Current applications and future directions.
    Diabet Med. 2026 Mar 28:e70299. doi: 10.1111/dme.70299.
    PubMed         Abstract available
    
    
14. DAVIES A, Grieve E, McCombie L, McIntosh A, et al
    Cost-effectiveness of the diabetes remission clinical trial (DiRECT)/Counterweight-Plus weight management programme, based on 5-year follow-up.
    Diabet Med. 2026 Mar 29:e70306. doi: 10.1111/dme.70306.
    PubMed         Abstract available
    
    
15. SCIBILIA R, Alvarez Pagola A
    The power of community: Advocacy for action on the psychosocial aspects of diabetes.
    Diabet Med. 2026 Mar 29:e70300. doi: 10.1111/dme.70300.
    PubMed        
    
    
16. CIGLER M, El-Hakouni O, Mecani R, Pouwer F, et al
    Exploring the gap between sensor-detected (SDH) and person-reported hypoglycaemia (PRH): The voice of people living with diabetes.
    Diabet Med. 2026 Mar 29:e70301. doi: 10.1111/dme.70301.
    PubMed         Abstract available
    
    
17. ASAAD M, Ghazaleh HA, Tzouvara V, Aljohani N, et al
    'Darkness as we face the unknown': Biopsychosocial-spiritual experiences of parents of children and young people with type 1 diabetes from the Middle East and North Africa (MENA) region.
    Diabet Med. 2026 Mar 29:e70303. doi: 10.1111/dme.70303.
    PubMed         Abstract available
    
    
18. TONGA E, Evans M, Oliver N, Ng SM, et al
    Exploring inequities in access to diabetes technologies among children and young people with type 1 diabetes: Perspectives of parents and young people from ethnic minority groups and low socio-economic areas.
    Diabet Med. 2026 Mar 29:e70304. doi: 10.1111/dme.70304.
    PubMed         Abstract available
    
    
19. LI Y, Qu K, Yang Q, Zhang J, et al
    The clinical spectrum and causal relationship assessment of checkpoint inhibitor-associated autoimmune diabetes mellitus (CIADM): A retrospective observational study.
    Diabet Med. 2026 Mar 31:e70316. doi: 10.1111/dme.70316.
    PubMed         Abstract available
    
    
20. HOMER V, Brophy C, French R, Krayem A, et al
    Mind the gap: Ongoing inequalities in glycaemic levels in young people living with Type 1 diabetes across England and Wales.
    Diabet Med. 2026 Mar 31:e70283. doi: 10.1111/dme.70283.
    PubMed         Abstract available
    
    
21. HUANG CJ, Yang SJ, Cheng CP, Lin CH, et al
    Efficacy and safety of switching to iGlarLixi from premixed insulin therapy in patients with type 2 diabetes: A real-world experience.
    Diabet Med. 2026 Apr 1:e70275. doi: 10.1111/dme.70275.
    PubMed         Abstract available
    
    
22. CHINENYE S, Erekosima I, Heald AH, Bozimo G, et al
    The development of type 2 diabetes amongst sibling pairs in the South-South region of Nigeria: The effect of genetics, environment and lifestyle.
    Diabet Med. 2026 Apr 1:e70278. doi: 10.1111/dme.70278.
    PubMed         Abstract available
    
    
23. DE WIT M, Klinker LY, Moore B, Boggiss A, et al
    Psychosocial aspects of early detection in type 1 diabetes: Language matters, decision making and support needs.
    Diabet Med. 2026 Apr 1:e70308. doi: 10.1111/dme.70308.
    PubMed         Abstract available
    
    
24. BERMAN MI, Burla M, Martin H, Fletcher M, et al
    Potential mechanisms for change in diabetes prevention programs: A systematic review.
    Diabet Med. 2026 Apr 3:e70249. doi: 10.1111/dme.70249.
    PubMed         Abstract available
    
    
25. LEWIS G, Hughes DM, Irving G, Wilding J, et al
    Real-world completion of diabetes self management education and its impact on patient-reported outcomes: A scoping review.
    Diabet Med. 2026 Apr 3:e70312. doi: 10.1111/dme.70312.
    PubMed         Abstract available
    
    

    
    Diabetes

26. YE J, Qiu Y, Aguilan JT, Sun Y, et al
    The Downregulation of Type 1 Diabetes Susceptibility Gene PGM1 Induces Metabolic Imbalance and Stress in Pancreatic beta-Cells.
    Diabetes. 2026 Mar 31:db250191. doi: 10.2337/db25-0191.
    PubMed         Abstract available
    
    
27. SOLLY EL, Luo Y, Primer KR, Mulangala J, et al
    Inhibition of miR-181c-5p Rescues Diabetes-Impaired Angiogenesis in Ischemia and Wound Healing.
    Diabetes. 2026 Mar 31:db240867. doi: 10.2337/db24-0867.
    PubMed         Abstract available
    
    
28. YU S, Wang F, Zhou X, Liang L, et al
    A Self-Reinforcing LGR5-Wnt/beta-Catenin-Nedd4L Circuit Drives Fibrotic Progression in Diabetic Kidney Disease.
    Diabetes. 2026 Apr 1:db250870. doi: 10.2337/db25-0870.
    PubMed         Abstract available
    
    

    
    Diabetes Care

29. HUTTASCH M, Kahl S, Mori T, Heilmann G, et al
    Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.
    Diabetes Care. 2026 Apr 2:dc253077. doi: 10.2337/dc25-3077.
    PubMed         Abstract available
    
    
30. CHRISTENSEN MH, Vinter CA, Petersen MH, Andersen MS, et al
    Diabetic Retinopathy in Parous Women With and Without Previous Gestational Diabetes Mellitus: A Nationwide Register-Based Cohort Study.
    Diabetes Care. 2026 Apr 2:dc253074. doi: 10.2337/dc25-3074.
    PubMed         Abstract available
    
    
31. KARAKUS KE, Clayton MG, Baschal EE, McDaniel KA, et al
    Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 Diabetes.
    Diabetes Care. 2026 Apr 2:dc252660. doi: 10.2337/dc25-2660.
    PubMed         Abstract available
    
    
32. WAN Y, Alessa HB, Guasch-Ferre M, Tobias DK, et al
    Intake of Fiber From Different Food Sources and Type 2 Diabetes Risk: An Integrated Analysis of Epidemiological and Multiomic Data.
    Diabetes Care. 2026 Apr 1:dc252957. doi: 10.2337/dc25-2957.
    PubMed         Abstract available
    
    
33. DAULTREY HE, Oliver NS, Chakera AJ, de la Cruz Libardi A, et al
    The Association Between Ambient Temperature and Hypoglycemia in People Living With Type 1 Diabetes: A Case Time Series Analysis Using Real-Time Continuous Glucose Monitoring.
    Diabetes Care. 2026 Mar 31:dc252383. doi: 10.2337/dc25-2383.
    PubMed         Abstract available
    
    
34. GUPTA RM, Ismail HM, Siller AF, Pesikoff J, et al
    Impact of Body Size on Preclinical Type 1 Diabetes Development and Progression.
    Diabetes Care. 2026 Mar 31:dci250134. doi: 10.2337/dci25-0134.
    PubMed         Abstract available
    
    
35. PAN M, Al-Sharify D, Engstrom G, Ahlqvist E, et al
    Genetic Susceptibility to Diabetes Subtypes and Risk of Developing Coronary Artery Disease.
    Diabetes Care. 2026 Mar 30:dc251711. doi: 10.2337/dc25-1711.
    PubMed         Abstract available
    
    
36. MAHER MD, Vigers T, Kohler C, Stecenko AA, et al
    Screening for Diabetes and Prediabetes in Cystic Fibrosis Using a Nonfasting 50-Gram 1-Hour Oral Glucose Challenge Test.
    Diabetes Care. 2026 Mar 30:dc252806. doi: 10.2337/dc25-2806.
    PubMed         Abstract available
    
    
37. BRAGG F, Alegre-Diaz J, Trichia E, Torres JM, et al
    Metabolomic Profile of Genetic Liability to Type 2 Diabetes Among 125,000 Mexican Adults: A Mendelian Randomization Study.
    Diabetes Care. 2026 Mar 27:dc252933. doi: 10.2337/dc25-2933.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

38. KATSURA M, Horiuchi Y, Tanabe K, Wettersten N, et al
    Real-World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non-Diabetic Adults.
    Diabetes Obes Metab. 2026 Mar 27. doi: 10.1111/dom.70721.
    PubMed         Abstract available
    
    
39. AHMED M, Shaikh N, Ibrahim S, Shafiq SB, et al
    Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Quality of Life and Patient-Reported Outcomes in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Diabetes Obes Metab. 2026 Mar 31. doi: 10.1111/dom.70714.
    PubMed         Abstract available
    
    
40. NESTI L, Santoni L, Baldi S, Scozzaro MT, et al
    Exercise Metabolic Flexibility in Type 2 Diabetes Treated With Empagliflozin: An Exploratory Analysis of the Randomised Trial EMPA-HEART.
    Diabetes Obes Metab. 2026 Mar 31. doi: 10.1111/dom.70727.
    PubMed         Abstract available
    
    
41. DUBSKY M, Liegertova M, Bem R, Sojakova D, et al
    Artificial Intelligence in Diabetes Care.
    Diabetes Obes Metab. 2026 Mar 30. doi: 10.1111/dom.70720.
    PubMed         Abstract available
    
    
42. ZAHARIEVA DP, Kingman RS, Lal RA, Nykaza E, et al
    Swimming With the Omnipod 5 Automated Insulin Delivery System: An Observational Investigation of Swimmers With Type 1 Diabetes in the Omnipod 5 Pivotal Trial.
    Diabetes Obes Metab. 2026 Mar 30. doi: 10.1111/dom.70715.
    PubMed         Abstract available
    
    
43. FERREIRA-DIVINO LF, Poulsen CG, Rotbain Curovic V, Urbak L, et al
    Albuminuria and Carotid Atherosclerosis in Type 1 Diabetes Evaluated Using Three-Dimensional Vascular Ultrasound.
    Diabetes Obes Metab. 2026 Mar 30. doi: 10.1111/dom.70695.
    PubMed         Abstract available
    
    
44. LIU Y, Wang Y, Wu W, Chen Y, et al
    Glycaemic Outcomes of a Novel Model-Predictive-Control-Based Hybrid Closed-Loop System in Chinese Adolescents and Adults With Type 1 Diabetes: A Multicentre Pivotal Trial.
    Diabetes Obes Metab. 2026 Mar 30. doi: 10.1111/dom.70709.
    PubMed         Abstract available
    
    
45. ALHAMDAN Y, Hsu JC, Lu CY
    Downstream Treatment Burden and Health-Care Utilization Following Initiation of GLP-1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Mar 30. doi: 10.1111/dom.70718.
    PubMed         Abstract available
    
    
46. PIPELLA J, Thompson PJ
    Toward Personalized Medicine in Type 1 Diabetes: Understanding How Patient Heterogeneity Influences Therapeutic Efficacy.
    Diabetes Obes Metab. 2026 Mar 30. doi: 10.1111/dom.70711.
    PubMed         Abstract available
    
    
47. GUO L, Luo X, Bi Y, Cao B, et al
    The Risk of Disease Progression of Type 1 Diabetes in First-Degree Relatives of People With Type 1 Diabetes: Design and Rationale of a Prospective, Longitudinal Study in China.
    Diabetes Obes Metab. 2026 Mar 30. doi: 10.1111/dom.70706.
    PubMed         Abstract available
    
    
48. PAPANIKOLAOU T, Elliott J, Sheth V, Quinn LM, et al
    From Screening to Delivery of Disease-Modifying Therapy: Real World Follow-Up of Children With Early-Stage Type 1 Diabetes.
    Diabetes Obes Metab. 2026 Mar 30. doi: 10.1111/dom.70689.
    PubMed        
    
    

    
    Diabetologia

49. SPIES R, Ufer G, Sabia R, Hummel J, et al
    Post-OGTT hypoglycaemia in newly diagnosed type 2 diabetes: frequency, characteristics and cluster assignment.
    Diabetologia. 2026 Mar 27. doi: 10.1007/s00125-026-06719.
    PubMed         Abstract available
    
    
50. OZDEDE M, Pavlou P, Krasniqi V, Athanasiadou KI, et al
    The impact of blood pressure variability and African Caribbean ethnicity on the progression of diabetic kidney disease in type 1 diabetes.
    Diabetologia. 2026 Apr 1. doi: 10.1007/s00125-026-06715.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

51. VADUGANATHAN M, Green JB, Heerspink HJL, Mann JFE, et al
    Early Hemodynamic Safety of Simultaneous Initiation of Finerenone and Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes: The CONFIDENCE Trial.
    J Am Coll Cardiol. 2026 Mar 24:S0735-1097(26)05495.
    PubMed        
    
    

    
    J Am Soc Nephrol

52. MOTTL A, Scott C, Green JB, Heerspink HJL, et al
    Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both: Post Hoc Analyses of CONFIDENCE Trial.
    J Am Soc Nephrol. 2026;37:764-776.
    PubMed         Abstract available
    
    

    
    J Biol Chem

53. HU R, Wang Y, Yagan M, Xu Y, et al
    Deregulated translation of the transcription factor Myt3 predisposes islet beta cells to dysfunction under obesity-induced metabolic stress.
    J Biol Chem. 2026;302:111164.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

54. ALSATAM ALRAOUI O, Borbjerg MK, Klonoff DC, Morch CD, et al
    Sleep quality and diabetic neuropathy: A review and exploratory meta-analysis.
    J Diabetes Complications. 2026;40:109311.
    PubMed         Abstract available
    
    
55. RONN PF, Svensson J, Wibaek R, Dabelea D, et al
    HbA1c trajectories and risk of albuminuria in children and adolescents with type 1 diabetes followed into adulthood - a joint modeling approach of Danish nationwide register data.
    J Diabetes Complications. 2026;40:109317.
    PubMed         Abstract available
    
    

    
    J Nutr

56. ASLAN S, Sozlu S
    Evaluating ChatGPT for Carbohydrate Counting Accuracy in Diabetes Management: A Precision Health Approach.
    J Nutr. 2026 Mar 30:101512. doi: 10.1016/j.tjnut.2026.101512.
    PubMed         Abstract available
    
    

    
    JAMA

57. MARSTON NA, Bohula EA, Bhatia AK, De Ferrari GM, et al
    Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial.
    JAMA. 2026 Mar 28:e263277. doi: 10.1001/jama.2026.3277.
    PubMed         Abstract available
    
    
58. 
    Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Research Summary.
    JAMA. 2026 Mar 28:e263429. doi: 10.1001/jama.2026.3429.
    PubMed        
    
    

    
    Metabolism

59. SONG W, Nie X, Zhu Z, Wang Q, et al
    Proteomics and metabolomics biomarkers for predicting the onset and progression of diabetic complications: A systematic review and bioinformatics integration.
    Metabolism. 2026 Mar 25:156601. doi: 10.1016/j.metabol.2026.156601.
    PubMed         Abstract available
    
    

    
    N Engl J Med

60. ROSEN CJ, Ingelfinger JR
    GLP-1 Receptor Agonists.
    N Engl J Med. 2026;394:1313-1324.
    PubMed         Abstract available
    
    

    
    Nutr Metab (Lond)

61. LIU Y, Wu J, Li N, Zhang S, et al
    Metabolic inflexibility mediates the association between type 2 diabetes and impaired post-exercise heart rate recovery: a mediation analysis.
    Nutr Metab (Lond). 2026 Mar 30. doi: 10.1186/s12986-026-01114.
    PubMed        
    
    

    
    Pediatr Diabetes

62. ARSLANIAN S, Barrett T, Shehadeh N
    Treatment of Youth-Onset Type 2 Diabetes: Focus on SGLT-2 Inhibitor Use.
    Pediatr Diabetes. 2026;2026:4555805.
    PubMed         Abstract available
    
    

    
    PLoS Genet

63. LEYDEN GM, Pagoni P, Power GM, Carslake D, et al
    An evaluation of age-varying genetic effects underlying body-mass index and blood pressure in the UK Biobank.
    PLoS Genet. 2026;22:e1012080.
    PubMed         Abstract available
    
    

    
    PLoS One

64. MUSA E, Chivese T, Werfalli M, Soepnel LM, et al
    Outcomes of hyperglycaemia in pregnancy in Africa: Systematic review and meta-analysis.
    PLoS One. 2026;21:e0345743.
    PubMed         Abstract available
    
    
65. ERDEM E, Duzgun G
    The effect of game-based education on adherence to treatment and anxiety level in type 2 diabetics started on insulin therapy.
    PLoS One. 2026;21:e0345292.
    PubMed         Abstract available
    
    
66. 
    Editorial Note: Machine learning-driven Diabetes Health Tracer (DHT): Optimizing prognosis using RaSK_GraDe and RaSK_GraDeL models.
    PLoS One. 2026;21:e0346001.
    PubMed        
    
    
67. THOMSON AM, McCarthy SF, Burr JF, Little JP, et al
    Testing the feasibility of blood flow restriction training to enhance the HEALTH benefits of exercise in individuals with type 2 diabetes (BOOST-HEALTH Trial): Study Protocol.
    PLoS One. 2026;21:e0346176.
    PubMed         Abstract available
    
    
68. WANG Y, Qu Y, Dong M, Zhang Y, et al
    Integrated transcriptome and single-cell sequencing analysis identify blood-pancreas shared lncRNA biomarkers in new-onset T2DM.
    PLoS One. 2026;21:e0345359.
    PubMed         Abstract available
    
    
69. SANDE L, Benade M, Tchereni T, Kamanga A, et al
    Facility-level integration of hypertension and diabetes services with HIV treatment in sub-Saharan Africa: Observational evidence from Malawi, South Africa, and Zambia.
    PLoS One. 2026;21:e0346029.
    PubMed         Abstract available
    
    
70. TIAN J, An J, Song L, Zhang W, et al
    Effect of ALA on preventing diabetic peripheral neuropathy in rats through mitochondrial axonal transport.
    PLoS One. 2026;21:e0346297.
    PubMed         Abstract available
    
    
71. YILDIRIM AN, Ahluwalia R, Baumgart JK, Cohen TR, et al
    Appetitive traits and their associations with metabolic health outcomes among adults living with prediabetes: Results from a cross-sectional study.
    PLoS One. 2026;21:e0336313.
    PubMed         Abstract available
    
    
72. SUMAWE JA, Salingwa L
    Doppler sonographic evaluation of peripheral arterial disease and its associated factors among diabetes mellitus patients at Muhimbili National Hospital, Tanzania: A hospital-based cross-sectional study.
    PLoS One. 2026;21:e0328852.
    PubMed         Abstract available
    
    
73. YAIKWAWONG M, Kamdee K, Mek-Yong K, Chuengsamarn S, et al
    Associations of tumor necrosis factor alpha genetic variants with metabolic syndrome and type 2 diabetes mellitus in a Thai population.
    PLoS One. 2026;21:e0346147.
    PubMed         Abstract available
    
    
74. ALI A, Mashwani ZU, Ahmad A, Luna-Arias JP, et al
    Elucidating the binding mechanism of Caralluma tuberculata metabolites with type 2 diabetes targets through molecular docking and dynamics simulations.
    PLoS One. 2026;21:e0343905.
    PubMed         Abstract available
    
    

    
    Retina

75. GOBLIRSCH TJ, Yu Y, Cardillo S, Hubbard RA, et al
    Racial and Ethnic Differences in Prevalence and Incidence of Diabetic Retinal Disease.
    Retina. 2026 Mar 31. doi: 10.1097/IAE.0000000000004836.
    PubMed         Abstract available
    
    

    
    Transplantation

76. RAO JS, Barra JM, Parmentier C, Chaudhry A, et al
    Advances in Beta-cell Replacement Therapy for Diabetes-Insights From the 20th International Pancreas and Islet Transplant Association (IPITA) World Congress, Pisa, 2025.
    Transplantation. 2026 Apr 3. doi: 10.1097/TP.0000000000005710.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum